WL LAW · 이우진 변호사·변리사
제약바이오 법무 · 계약 검토 · 라이선싱 · 임상 · IP 분쟁
www.biopharmlaw.com
자문 의뢰하기 →
본문 바로가기

— PHARMA · BIOTECH · LIFE SCIENCE LEGAL

과학과 법률,
두 언어로
말합니다

WL LAW | 이우진 변호사 · 변리사 · 뇌과학 박사

연구용역부터 임상시험, 라이선싱 딜 그리고 IP 분쟁까지 —
제약바이오 업계의 복잡한 법률 이슈를 연구자 출신 변호사가 해결합니다.

이우진 변호사

업계동향 카테고리

[Korean News] South Korea's Telemedicine Industry, where are we at?

The Korean telemedicine industry has been experiencing significant growth and transformation, spurred by advancements in technology and changes in healthcare delivery models. Although so far, South Korea's regulatory environment has not been so friendly for the telemedicine industry, limiting the scope of telemedicine services, there have been many efforts to expand telemedicine regulations to accommodate technological advancements and changing healthcare needs.

During the COVID pandemic, this unprecedented experience has accelerated the adoption of telemedicine globally, including in South Korea. As social distancing measures and lockdowns restricted in-person healthcare visits, telemedicine emerged as a crucial alternative for patients to receive medical advice and treatment while minimizing the risk of virus transmission. As a result, the South Korean government has recognized the potential benefits of telemedicine in improving healthcare accessibility, especially in remote areas. Government Initiatives have been introduced to promote telemedicine adoption, such as pilot projects and funding for telemedicine infrastructure development.

Telemedicine services in South Korea are gradually being integrated into the broader healthcare system. Hospitals and clinics are incorporating telemedicine capabilities into their practice, enabling patients to access healthcare services remotely. However, some challenges remain, such as concerns for patient privacy, reimbursement issues, and regulatory compliance. 

Recently South Korean President YoonSuk Yeol emphasized that non-face-to-face medical treatment should be viewed from the perspective of developing the bio-medical industry and that administrative purposes should be achieved by nurturing the industry rather than regulation during a public discussion in January 2024. (Reference: President Yoon gives a boost to ‘telemedicine’ industry)

Overall, the Korean telemedicine industry is evolving rapidly, driven by technological innovation, changing healthcare needs, and government support. While challenges persist, the industry holds significant potential to enhance healthcare accessibility and delivery in South Korea.